Joseph Martz, MD
Surgery · New York, NYNPI 1164404158
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 99.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $8,417 and has fallen 53.2% since, to $3,937 in 2025.
Across 20 payments — averaging $706.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Johnson & Johnson$117
- Bristol Myers Squibb$15
Across 10 payments — averaging $6982.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Reddress LTD$44K
- Takeda Pharmaceuticals U.S.A., Inc.$26K
What the payments were for
- Speaking & faculty fees$4,00028%
- Travel & lodging$1,80613%
- Food & beverage$5334%
- Education$7,79455%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $14,000 |
| Johnson & Johnson | 1 | $117 |
| Bristol Myers Squibb | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$11,282
- DA VINCI SP$2,500
- Echelon Circular$117
How this compares
$14,132 in reported general payments places this provider in the 85th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LoperamideLoperamide Hcl | 12 | $356 |
| Oxycodone Hcl | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other surgery in New York
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$695K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Rache SimmonsNew York$371K
- Marina KurianNew York$328K
- Megan JenkinsNew York$290K
- Brian JacobNew York$225K
- Robin BlackstoneNew York$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.